2017. EULAR Annual Congress – Early response to certolizumab pegol in rheumatoid arthritis predicts outcome: Data from a prospective observational study

Saraux A, Flipo RM, Fagnani F, Massol J, Combe B, Huot-Marchand P, et al. Early response to certolizumab pegol in rheumatoid arthritis predicts outcome: Data from a prospective observational study. Ann Rheum Dis. 2017;76(suppl 2):786. Presented at: EULAR 2017; June 14-17, 2017; Madrid, Spain.